Guanylin (human) (trifluoroacetate salt) |
| Catalog No.GC49048 |
A peptide hormone activator of GC-C
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: N/A
Sample solution is provided at 25 µL, 10mM.
;)
_1-7.$$$37316672@70.jpg');)
;)
;)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
;)
;)
;)
_1124-1138.$$$35908550@30.jpg');)
_766-780.$$$37100057@30.jpg');)
_418-432.$$$36893736@30.jpg');)
_240-255.$$$35108512@29.jpg');)
_533-545.$$$36543525@28.jpg');)
_264-276.$$$36600053@22.jpg');)
_2214998.$$$@0.jpg');)
Guanylin is a peptide hormone activator of membrane-bound guanylate cyclase C (GC-C).1,2 It contains four cysteines that can form disulfide bridges leading to two possible isoforms, with the active form containing disulfide bridges between Cys4 and Cys12 and Cys7 and Cys15.1 Guanylin is found in epithelial cells of the small intestine where it activates GC-C to increase intestinal chloride and fluid secretion.2,3,4 Guanylin expression is reduced by 100- to 1,000-fold in greater than 85% of isolated tumors from patients with colorectal cancer compared with adjacent non-cancerous intestinal epithelial tissue.5
1.Nokihara, K., Wray, V., Ando, E., et al.Synthesis, solution structure, binding activity, and cGMP activation of human guanylin and its disulfide isomerRegul. Pept.70(2-3)111-120(1997) 2.de Sauvage, F.J., Keshav, S., Kuang, W.-J., et al.Precursor structure, expression, and tissue distribution of human guanylinProc. Natl. Acad. Sci. USA89(19)9089-9093(1992) 3.Hill, O., Kuhn, M., Zucht, H.-D., et al.Analysis of the human guanylin gene and the processing and cellular localization of the peptideProc. Natl. Acad. Sci. USA92(6)2046-2050(1995) 4.Forte, L.R., and Currie, M.G.Guanylin: A peptide regulator of epithelial transportFASEB J.9(8)643-650(1995) 5.Wilson, C., Lin, J.E., Snook, A.E., et al.The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancerCancer Epidemiol. Biomarkers Prev.23(11)2328-2337(2014)
| Cas No. | N/A | SDF | |
| Canonical SMILES | O=C(N[C@H](C(N[C@H](C(N[C@](CSSC[C@]1([H])NC([C@@]([C@H](O)C)([H])NC(CNC([C@@H]2CCCN2)=O)=O)=O)([H])C(N[C@@](C3=O)([H])[C@H](O)C)=O)=O)C)=O)C)[C@](NC([C@@H](NC([C@@](CSSC[C@H](NC(CN3)=O)C(O)=O)([H])NC(C(NC([C@@H](NC1=O)CCC(O)=O)=O)[C@@H](C)CC)=O)=O)C)=O)([H])CC(C=C4)=CC=C4O.OC(C(F)(F)F)=O | ||
| Formula | C58H87N15O21S4·XCF3COOH | M.Wt | 1458.7 |
| Solubility | Water: 1 mg/ml | Storage | -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 0.6855 mL | 3.4277 mL | 6.8554 mL |
| 5 mM | 0.1371 mL | 0.6855 mL | 1.3711 mL |
| 10 mM | 0.0686 mL | 0.3428 mL | 0.6855 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5 (Based on Reviews and 20 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *